A detailed history of Phoenix Holdings Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 66,726 shares of PFE stock, worth $1.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
66,726
Previous 76,510 12.79%
Holding current value
$1.71 Million
Previous $2.14 Million 9.77%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$27.7 - $31.39 $271,016 - $307,119
-9,784 Reduced 12.79%
66,726 $1.93 Million
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $306,151 - $358,752
-12,120 Reduced 13.67%
76,510 $2.14 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $816,311 - $937,386
-31,530 Reduced 26.24%
88,630 $2.46 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $579,746 - $753,026
-22,187 Reduced 15.59%
120,160 $3.46 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $443,002 - $517,825
-13,805 Reduced 8.84%
142,347 $4.72 Million
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $4.89 Million - $5.66 Million
135,510 Added 656.48%
156,152 $5.73 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $223,617 - $291,116
5,677 Added 37.94%
20,642 $842,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $624,788 - $815,592
14,965 New
14,965 $767,000
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $2.82 Million - $3.58 Million
-84,158 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $696,118 - $816,706
21,925 Added 35.23%
84,158 $2.88 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $69,878 - $84,772
2,320 Added 3.87%
62,233 $1.92 Million
Q1 2020

May 20, 2020

BUY
$27.03 - $38.62 $1.62 Million - $2.31 Million
59,913 New
59,913 $1.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.